BU BÖLÜM HAKKINDA
Biomedical scientist Andrea Love highlights the inconsistency in public acceptance of genetic engineering—embraced in medicine but often rejected in agriculture. She argues that the same scientific tools used to treat cancer and genetic diseases can also save lives through innovations like Golden Rice, and warns that misinformation and ideology are blocking progress where it's needed most.
Read this article and find accompanying references at:
About the Author:
Dr. Andrea Love is an immunologist and microbiologist with over a decade of experience in basic sciences, translational medicine, and clinical research. She is a subject-matter expert in infectious disease immunology, cancer immunology, and autoimmunity and is adept at translating complex scientific data and topics for the public and healthcare providers. She works full-time in life science biotechnology in the fields of vaccinology, immunology, immunotherapy, cancer, cell and gene therapy, and other related fields. While she will always be a biomedical scientist, she has a passion for helping the public understand complex science topics in order to navigate the world better. She is also the author of Immunologic, a newsletter and science information hub that communicates evidence-based information on science and health topics. Andrea is also the Executive Director of the American Lyme Disease Foundation, and was the 2023 American Medical Writers Association McGovern Award Recipient. She is passionate about scientific literacy starting from an early age and encouraging children toward a career in STEM. Outside of her career in science and efforts in science communication, she lives near Philly with her partner and their 7 rescue cats. She is a marathoner and ultramarathoner, a yogi, a black belt in judo, and an amateur wildlife photographer.
Subscribe to Skeptical Inquirer: https://skepticalinquirer.org/subscribe/
Skeptical Inquirer Audio Edition is a production of the Committee for Skeptical Inquiry and the Center for Inquiry.
